Abstract
Mullerian adenosarcoma of the uterus is a biphasic tumor exhibiting benign epithelial and malignant stromal component. This tumor may occasionally be associated with tamoxifen therapy which is used as an adjuvant drug for breast carcinoma. Reviewing the literature, we found only 12 adenosarcoma cases associated with tamoxifen therapy Thus, the clinical and pathological findings in a 58 years old postmenopausal woman who developed uterine adenosarcoma, following low dose tamoxifen therapy after 8 years, was discussed in this report.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 30 November 1999 / Accepted: 9 March 2000
Rights and permissions
About this article
Cite this article
Arici, D., Aker, H., Yildiz, E. et al. Mullerian adenosarcoma of the uterus associated with tamoxifen therapy. Arch Gynecol Obstet 264, 105–107 (2000). https://doi.org/10.1007/s004040000080
Issue Date:
DOI: https://doi.org/10.1007/s004040000080